Diametric Capital’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,800
Closed -$206K 478
2023
Q1
$206K Buy
+22,800
New +$199K 0.1% 231
2022
Q3
Sell
-30,002
Closed -$159K 348
2022
Q2
$159K Buy
+30,002
New +$181K 0.12% 216
2020
Q3
Sell
-18,110
Closed -$653K 191
2020
Q2
$653K Sell
18,110
-3,359
-16% -$124K 0.5% 67
2020
Q1
$762K Sell
21,469
-27,425
-56% -$1.12M 0.92% 40
2019
Q4
$2.22M Sell
48,894
-30,843
-39% -$1.12M 1.62% 17
2019
Q3
$1.98M Buy
+79,737
New +$2M 1.63% 18

Other funds holding ZYME

Diametric Capital's ZYME Position: Q2 2023 in Review

Diametric Capital sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 22,800 shares — an estimated $206K sold.

Diametric Capital first reported a position in ZYME in Q3 2019 and held it in 6 quarters. The position peaked at $2.22M in Q4 2019. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Diametric Capital reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Diametric Capital sold 22,800 Zymeworks shares in Q2 2023, an estimated $206K.
  • Diametric Capital first reported a position in Zymeworks in Q3 2019 and held it in 6 quarters.
  • Diametric Capital's Zymeworks position peaked at $2.22M in Q4 2019.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Diametric Capital's 13F filing for Q2 2023, filed 11 Aug 2023.